These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 5620686

  • 21. [Clinical importance of primary resistance to major drugs in pulmonary tuberculosis patients].
    Balestrino E, Pio A.
    Torax; 1967 Jun; 16(2):64-9. PubMed ID: 5614163
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical use of capromycin in pulmonary tuberculosis].
    Zierski M, Bek E.
    Gruzlica; 1969 Jul; 37(7):649-57. PubMed ID: 4900503
    [No Abstract] [Full Text] [Related]

  • 24. [New aspects in the control and treatment of chronic pulmonary tuberculosis].
    Milutinović R, Zigić M, Ilić M.
    Plucne Bolesti Tuberk; 1974 Jul; 26 Suppl 2():79-86. PubMed ID: 4614297
    [No Abstract] [Full Text] [Related]

  • 25. A clinical study on controlled therapy in newly-diagnosed pulmonary tuberculosis using combinations of antituberculosis drugs by the daily continuous and intermittent methods.
    Arch Immunol Ther Exp (Warsz); 1976 Jul; 24(2):169-84. PubMed ID: 1275660
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Considerations on drug-resistent tuberculosis patients admitted to G. Saint-Bois Hospital during the years 1966 to 1970].
    Piñeyro JA, Bazerque E, Fossemalle JR, Tarallo NH.
    Hoja Tisiol; 1971 Jul; 28(1-2):77-88. PubMed ID: 5006266
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Ethambutol monotherapy in chronic drug-resistant pulmonary tuberculosis].
    Ferraro U, Briccarello L, Vercellino E.
    G Ital Mal Torace; 1968 Jul; 22(4):195-201. PubMed ID: 5743001
    [No Abstract] [Full Text] [Related]

  • 31. [Current incidence of primary resistance in hospitals].
    Girbal JP, Orlando JP, Taranger J, Charpin J.
    Mars Med; 1972 Jul; 109(11):776-8. PubMed ID: 4662244
    [No Abstract] [Full Text] [Related]

  • 32. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R.
    Kekkaku; 1968 Dec; 43(12):520-1. PubMed ID: 5716117
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Polychemotherapy of bacteriologically positive pulmonary tuberculosis in patients with the treatment duration of over 10 years].
    Panajotović H, Marsenić B.
    Plucne Bolesti Tuberk; 1972 Dec; 24(1):30-4. PubMed ID: 5045386
    [No Abstract] [Full Text] [Related]

  • 36. A controlled trial of three regimens of self-administered and supervised chemotherapy for pulmonary tuberculosis. B. Bacteriological report.
    Rist N.
    Bull Int Union Tuberc; 1970 Aug; 44():38-53. PubMed ID: 4916797
    [No Abstract] [Full Text] [Related]

  • 37. Anti-tuberculosis drug resistance in the West Province of Cameroon.
    Kuaban C, Bercion R, Noeske J, Cunin P, Nkamsse P, Ngo Niobe S.
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):356-60. PubMed ID: 10777086
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical experiences with the new antitubercular agent Myambutol].
    Kilic S.
    Med Klin; 1968 Dec 20; 63(51):2082-5. PubMed ID: 5730449
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.